NGD and Sheba Launch Partnership to Study Drug-Resistant Bacteria

At the intersection of world-leading biotech innovation and medical excellence, a groundbreaking partnership is emerging that could transform how hospitals worldwide detect and fight their most challenging bacterial infections. 

There’s something of science-fiction about peering into the genetic code of microscopic enemies to stop them in their tracks, and that’s exactly what’s happening through a remarkable new collaboration. Sheba Medical Center, ranked among the World’s Best Hospitals by Newsweek for eight consecutive years, has joined forces with Next Gen Diagnostics (NGD), a world leader in pathogen bioinformatics, to crack one of medicine’s most stubborn puzzles: highly antibiotic-resistant bacterial infections. 

This collaboration combines NGD’s validated machine learning models for whole genome sequence-based detection with Sheba’s unique collection of resistant bacterial strains. The partnership brings together NGD’s world-leading automation of pathogen bioinformatics and their unique NGD100 microfluidic sample preparation instrument with Sheba’s comprehensive clinical expertise.